Literature DB >> 16368459

The current burden of pneumococcal disease in England and Wales.

A Melegaro1, W J Edmunds, R Pebody, E Miller, R George.   

Abstract

OBJECTIVE: To evaluate the potential impact of various pneumococcal conjugate vaccination strategies, it is critical to ascertain the pre-vaccination epidemiology and to have a detailed evaluation of the current burden of pneumococcal disease.
METHOD: A variety of national data sources and GP sentinel surveillance systems were used to estimate the incidence, number of hospital admissions, deaths, and GP consultations due to pneumococcal disease in England and Wales. Clinical outcomes included pneumococcal meningitis, bacteraemia, pneumonia and otitis media. A statistical model was used to attribute GP consultation recorded as pneumonia and acute otitis media to specific aetiological causes when these were not recorded.
RESULTS: The burden of pneumococcal disease is considerable, with incidence rates of both invasive and non-invasive disease peaking in children (<5 years) and in the elderly (75+ years). Around 5800 hospitalisations specifically mentioning Streptococcus pneumoniae are estimated to occur annually in England and Wales, almost 40,000 for lobar pneumonia and over 15,000 for otitis media. There may be an additional 70,000 GP consultations for pneumococcal related community acquire pneumonia and over 630,000 for otitis media. A significant proportion of hospitalisations and GP consultations for pneumococcal disease occur among high-risk groups, with over 80% of hospital admissions reporting more than one diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368459     DOI: 10.1016/j.jinf.2005.02.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  38 in total

1.  Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

Authors:  R G Pebody; J Hippisley-Cox; S Harcourt; M Pringle; M Painter; G Smith
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

2.  Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults.

Authors:  Filippo Ansaldi; Andrea Orsi; Cecilia Trucchi; Daniela De Florentiis; Antonella Ceravolo; Martina Coppelli; Sergio Schiaffino; Valter Turello; Roberto Rosselli; Roberto Carloni; Giancarlo Icardi; Ligurian Pneumococcal Study Group; Paola Canepa; Laura Sticchi; Roberta Zanetti; Ilaria Cremonesi; PierClaudio Brasesco; Paolo Moscatelli
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study.

Authors:  Mehmet Ceyhan; Nezahat Gürler; Yasemin Ozsurekci; Melike Keser; Ahmet Emre Aycan; Venhar Gurbuz; Nuran Salman; Yildiz Camcioglu; Ener Cagri Dinleyici; Sengul Ozkan; Gulnar Sensoy; Nursen Belet; Emre Alhan; Mustafa Hacimustafaoglu; Solmaz Celebi; Hakan Uzun; Ahmet Faik Oner; Zafer Kurugol; Mehmet Ali Tas; Denizmen Aygun; Eda Karadag Oncel; Melda Celik; Olcay Yasa; Fatih Akin; Yavuz Coşkun
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

4.  Pneumococcal serotypes causing pediatric meningitis in Turkey: application of a new technology in the investigation of cases negative by conventional culture.

Authors:  M Ceyhan; I Yildirim; C L Sheppard; R C George
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-20       Impact factor: 3.267

5.  Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.

Authors:  Alessia Melegaro; Yoon Hong Choi; Robert George; W John Edmunds; Elizabeth Miller; Nigel J Gay
Journal:  BMC Infect Dis       Date:  2010-04-08       Impact factor: 3.090

6.  The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine.

Authors:  Adrienne Morrow; Philippe De Wals; Geneviève Petit; Maryse Guay; Lonny James Erickson
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

7.  Comparative role of immunoglobulin A in protective immunity against the Bordetellae.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Elizabeth M Goebel; Eric T Harvill
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

Review 8.  Pneumococcal Capsular Polysaccharide Immunity in the Elderly.

Authors:  Hugh Adler; Daniela M Ferreira; Stephen B Gordon; Jamie Rylance
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

9.  Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults.

Authors:  Daniela M Ferreira; Daniel R Neill; Mathieu Bangert; Jenna F Gritzfeld; Nicola Green; Adam K A Wright; Shaun H Pennington; Laura Bricio-Moreno; Laura Bricio Moreno; Adriana T Moreno; Eliane N Miyaji; Angela D Wright; Andrea M Collins; David Goldblatt; Aras Kadioglu; Stephen B Gordon
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

Review 10.  Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Authors:  Catherine Weil-Olivier; Mark van der Linden; Iris de Schutter; Ron Dagan; Lorenzo Mantovani
Journal:  BMC Infect Dis       Date:  2012-09-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.